The RadExIORSBoost project team members participated in Workshop 6, held from 2-6 February 2026. Hosted at the Institute of Oncology Ljubljana in Slovenia, this hybrid scientific event focused on the topic: “Radiosensitisation of malignant tumors with electroporation-based therapies”.
Throughout the week, experts from the RadExIORSBoost consortium shared cutting-edge research and methodologies. Sessions led by Dr. Urška Kamenšek and Dr. Maša Omerzel explored plasmid vectors in cancer therapy, molecular cloning, and DNA sensing after gene electrotransfer. Dr. Boštjan Markelc and Dr. Simona Kranjc Brezar discussed the vascular effects of electroporation and the application of electrochemotherapy in radiosensitization. Researchers from the Medical University of Vienna (MUW), Prof. Dr. Siegfried Knasmüller and Dr. Miroslav Mišik presented a two-part review on radiation-induced DNA damage for predicting adverse effects in prostate cancer patients treated with radiotherapy. Dr. Tanja Jesenko highlighted radiosensitization techniques using anti-angiogenic plasmids targeting endoglin (CD105).
A key highlight of the workshop was the Round Table: Radiobiology 2026–2030 moderated by Prof. Dr. Maja Čemažar. Panelists from IORS, MUW, UHEI, and OI LJUBLJANA discussed the Capabilities, Gaps, and a Joint Research Roadmap for the future of radiobiology research over the next five years.
This workshop continues to “raise the bar” in networking and technological innovation in radiobiology, bringing us closer to individual radiosensitivity prediction.
The RadExIORSBoost project team would like to thank the team from the Institute of Oncology Ljubljana for the excellent organization and scientific programme of the workshop.
